1. Home
  2. CHH vs ADMA Comparison

CHH vs ADMA Comparison

Compare CHH & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHH
  • ADMA
  • Stock Information
  • Founded
  • CHH 1939
  • ADMA 2004
  • Country
  • CHH United States
  • ADMA United States
  • Employees
  • CHH N/A
  • ADMA N/A
  • Industry
  • CHH Hotels/Resorts
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CHH Consumer Discretionary
  • ADMA Health Care
  • Exchange
  • CHH Nasdaq
  • ADMA Nasdaq
  • Market Cap
  • CHH 5.8B
  • ADMA 5.1B
  • IPO Year
  • CHH 1997
  • ADMA N/A
  • Fundamental
  • Price
  • CHH $122.88
  • ADMA $17.74
  • Analyst Decision
  • CHH Hold
  • ADMA Strong Buy
  • Analyst Count
  • CHH 14
  • ADMA 4
  • Target Price
  • CHH $133.64
  • ADMA $24.25
  • AVG Volume (30 Days)
  • CHH 402.3K
  • ADMA 2.7M
  • Earning Date
  • CHH 08-07-2025
  • ADMA 08-07-2025
  • Dividend Yield
  • CHH 0.94%
  • ADMA N/A
  • EPS Growth
  • CHH 40.19
  • ADMA N/A
  • EPS
  • CHH 6.57
  • ADMA 0.84
  • Revenue
  • CHH $797,663,000.00
  • ADMA $459,381,000.00
  • Revenue This Year
  • CHH $103.49
  • ADMA $23.35
  • Revenue Next Year
  • CHH $3.35
  • ADMA $27.67
  • P/E Ratio
  • CHH $18.54
  • ADMA $21.27
  • Revenue Growth
  • CHH N/A
  • ADMA 62.23
  • 52 Week Low
  • CHH $116.13
  • ADMA $10.21
  • 52 Week High
  • CHH $157.86
  • ADMA $25.67
  • Technical
  • Relative Strength Index (RSI)
  • CHH 41.14
  • ADMA 32.83
  • Support Level
  • CHH $121.42
  • ADMA $20.42
  • Resistance Level
  • CHH $131.40
  • ADMA $22.37
  • Average True Range (ATR)
  • CHH 2.82
  • ADMA 0.88
  • MACD
  • CHH -0.57
  • ADMA -0.28
  • Stochastic Oscillator
  • CHH 15.14
  • ADMA 1.07

About CHH Choice Hotels International Inc.

As of Dec. 31, 2024, Choice Hotels operated 654,000 rooms across the economy, midscale, upscale, and extended-stay segments. Comfort Inn and Comfort Suites are the largest brands (26% of the company's total domestic rooms), while Ascend and Cambria (10% of total domestic rooms) are newer lifestyle and select-service brands. Choice closed on its Radisson acquisition in August 2022, which added about 70,000 rooms. Franchises account for 100% of total revenue, and the United States represent 78% of total rooms in 2024.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

Share on Social Networks: